Docoh
Loading...

QGEN Qiagen

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Company profile

Ticker
QGEN
Exchange
Website
CEO
Thierry Bernard
Employees
Incorporated
Location
Fiscal year end
Former names
QIAGEN NV
SEC CIK

QGEN stock data

(
)

Calendar

4 Mar 21
18 May 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Qiagen earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

53.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 265 246 +7.7%
Opened positions 61 52 +17.3%
Closed positions 42 77 -45.5%
Increased positions 111 75 +48.0%
Reduced positions 58 83 -30.1%
13F shares
Current Prev Q Change
Total value 7.7B 7.25B +6.2%
Total shares 121.3M 99.02M +22.5%
Total puts 500.92K 522.5K -4.1%
Total calls 2.32M 804.2K +188.2%
Total put/call ratio 0.2 0.6 -66.7%
Largest owners
Shares Value Change
Davidson Kempner Capital Management 16.5M $855.8M -9.7%
Massachusetts Financial Services 11.78M $622.73M NEW
Vanguard 7.44M $393.27M +0.3%
FIL 5.9M $304.29M +35.4%
BLK Blackrock 4.7M $248.26M +2.5%
Millennium Management 4.28M $226.13M -6.1%
Wellington Management 4.21M $219.04M +17.0%
DB Deutsche Bank AG - Registered Shares 4.19M $221.65M +22.6%
Norges Bank 4.02M $208.21M NEW
Amundi Pioneer Asset Management 3.44M $181.9M +12.0%
Largest transactions
Shares Bought/sold Change
Massachusetts Financial Services 11.78M +11.78M NEW
Norges Bank 4.02M +4.02M NEW
Farallon Capital Management 3.26M +3.26M NEW
C Citigroup 2.76M +1.83M +197.9%
CS Credit Suisse 896.22K -1.78M -66.5%
Davidson Kempner Capital Management 16.5M -1.78M -9.7%
FIL 5.9M +1.54M +35.4%
IVZ Invesco 2.48M +1.53M +162.4%
Premier Fund Managers 1.11M +1.11M NEW
ATAC Neuberger Berman 1.08M +1.06M +5865.9%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: Alliance, anchored, antibody, antigen, ArcherDX, art, attrition, Augsburg, AWE, bad, bargaining, Bearer, Besluit, blended, bulk, career, carryforward, cart, CFO, Champion, childcare, choice, conservation, COVID, dashboard, Decree, delisting, driven, easier, easily, eHub, eighty, EPA, epidemiological, Epitect, EPS, Ernst, ESG, EUA, EUDAMED, exciting, fashion, FDCA, fear, foster, freedom, Haag, Handelsunion, harassment, HITECH, hour, Huttopia, instelling, intimidation, intranet, Invitae, IVCT, Kiel, leaving, lifted, Lonza, MedTech, MHRA, mix, mobilized, narrow, ninety, nondeductibility, nontaxable, Northern, noteholder, NVTA, OncoCyte, openly, OSCE, outperform, pandemic, passion, QIAprep, QIAreach, QIAstat, Quebec, ran, Recovery, remarkable, remediate, renovate, reorder, reprisal, Reproductive, retaliation, revoked, reward, Rheinland, saliva, Scorpion, Scotland, Seal, Secretary, signaled, Simplification, SRD, stay, steep, strictly, strive, struck, Subtitle, therewith, Thyssen, TMO, Toralf, turnover, UK, UKCA, unaudited, vaccine, Verifying, Voith, voluntary, widest, Young
Removed: AB, Acino, Acknowledgement, addressing, aim, Alere, alienation, antibiotic, antiviral, applicant, approvable, arithmetic, Astra, AstraZeneca, Avista, Baker, BIOBASE, biopsy, Biovitrum, BONESUPPORT, breast, bridging, buyback, Canada, capitalization, careHPV, Carolina, Cary, centrifugation, certificate, cesium, check, checked, chloride, CLC, clinically, Coloplast, compound, connect, consistently, coupled, Danisco, debit, density, denying, detecting, diagnosing, DiaSorin, differentiating, digene, divestiture, Draco, EGFR, EGM, embrace, encryption, endorsement, Facsimile, Fax, fight, fighting, filer, focusing, foot, freeing, front, gastrointestinal, GeneRead, GeneReader, Gottlieb, gradient, grew, guiding, head, immunocompromised, immunosuppressive, infection, influenza, Institutet, Interpreta, interpreting, Karolinska, letter, LTBI, Lundbeck, lung, matured, McKenzie, mine, modern, module, momentum, multimodal, multinational, Neuroscience, North, Nycomed, operative, organizational, Orphan, phenol, PHI, play, polymerase, precipitation, precise, preclinical, PRIMECAP, profound, proper, purify, purity, QIAcube, qPCR, QSR, qualitative, question, reaction, returned, satisfaction, Scandinavian, Schatz, Scott, screen, seasoned, shell, simpler, skin, Sobi, solid, SP, standalone, Statue, sterling, stipulated, substance, supplied, surface, surpassed, sustainably, Suzhou, Sweden, Swedish, Switzerland, targeting, TB, Tel, Timetable, transferee, translating, transmit, transplant, transplantation, Trump, tuberculin, unchanged, underway, Unresolved, weaker, widespread, withdrawn

Proxies

No filings